Given the first WD40 domain of Gnb5 (Gnb5 (28-102aa)) is essential for its binding with BACE1 and the S81L mutation disrupts its role, we wondered whether this protein fragment could attenuate AD pathology in vivo. This evidence concerns the gene BACE1 and Alzheimer disease.